md_a
Member
- Joined
- Aug 31, 2015
- Messages
- 468
DOCUMENTATION
The following diagram shows how SARS-CoV-2 is passed from person to person through respiratory droplets. Once inside the body the virus will invade our cells and reproduce itself. In response to the virus our immune system will attack the invader launching first a response from T-cells designed to kill the cells infected with the virus and later an antibody response designed to kill the virus before it gets into another cell.This diagram also shows how too much of a good thing can cause harm to the body. When our VIRAL immune response, either because of other health problems we have (comorbidities) produce too much response OR because there is too much of the virus (e.g. vaccines) in our body; the outcome is INFLAMMATION and BLOOD CLOTTING (InflammoThrombotic Response – ITR) that can kill us (COVID-19).
The document numbers listed on the diagram below match the numbered documents providing links to the research as well as other materials not only explaining these issues but also the Gain-of-Function (GoF) research responsible for the development of this man-made virus.
SARS-CoV-2: Documents 17, 20.
InflammoThrombotic Response (ITR): Documents 18, 19, 21, 33, 37, 49.
Treatments: Document 40.
Gain-of-Function (With HIV-gp120; PRRA & Prion-like Domain): Documents 7, 9, 14, 15, 16, 21, 22, 26, 35, 36, 38, 39, 41, 42, 43, 44, 45, 46, 47, 48, 50, 54, 56, 57.
BIOWEAPON: 58, 59, 60, 61, 62.
Vaccines: Documents 1, 2, 3, 13, 24, 31, 32, 51, 52, 53, 55, 56.
Enters Nucleus with DNA: Documents 10, 11, 12, 63, 64.
Antibody Dependent Enhancement of Virus: Documents 4, 5, 6.
Neurologic - Central Nervous System - Brain: 8, 23, 25, 27, 28, 29, 30, 34.
1. EUA Requirements by FDA
October 20202. Pfizer EUA document
December 10, 20203. Moderna EUA Document
December 17, 20204. SARS-CoV-1 Antibody Dependent Enchancement (ADE)
July 5, 20115. ADE shown in animals including primates
January 2, 20216. ADE (Osaka Paper) showing antibodies to NTD increase infectivity of SARS-CoV-2
December 18, 20207. Prion-like Domains
March 29,, 20208. Amyloid Precursor Proteins and Neurologic Disease
May 21, 20199. Amyloidosis and Prion Diseases
October 26, 201010. SARS-CoV-2 RT back into human DNA
December 13, 202011. Platlets and LINE-1 to Generate RNA-DNA Hybrids with Reverse Transcriptase
April 201812. Reverse Transcription Produces Mechanism for Long Term Survival and Recurrent Infections
January 9, 201913. Pfizer vaccines contains 13 billion mRNA repetitions in the low dose of 30-micrograms.
December 25, 202014. Baric & Zhengli Shi re-engineer the HKU4 spike to increase Corona Virus Infectivity. Gain-of-Function (GoF)
September 201515. SARS-CoV-2 Gain-of-Function Hall of Shame
October 1, 202016. Evidence that SARS-CoV-2 is not naturally evolved
July 1, 202017. South African Mutation of SARS-CoV-2
December 22, 202018. InflammoThrombotic Response (ITR)
August 18,202019. Massive Blood Clots Kill COVID Patients
January 9, 201920. Cryo-Electron Tomography of SARS-CoV-2 showing spike proteins
October 9, 202021. PRRA Superantigen increases inflammation
October 13, 202022. PRRA Insert essential for infection of human lung cells and brain
May 1, 202023. SARS-CoV-2 Spike protein crosses the blood brain barrier in mice study
December 16, 202024. Neurological adverse events associated with vaccines
June 200225. SARS-CoV-2 Invades Brain
November 30, 202026. Neuropilin-1binds to Furin (PRRA) Cleavage site to increase Infectivity.
November 13, 202027. Spike Protein Crosses BBB to Infect Brain
November 30, 202028. Fatal Invasion of Brain by SARS-CoV-2 Depends upon ACE2.
January 15, 202129. SARS-CoV-2 Interferes With Recognition of the Severity of Hypoxemia.
July 28, 202030. RNA can Behave like Prions.
July 1, 202031. Influenza mRNA Spreads Throughout Body and Found in Lungs, Brain, Heart for 14-days.
October 199532. Moderna mRNA Vaccine for Influenza Spreads Throughout Body.
March 24, 201733. How Immune Cells Cross the Blood-Brain Barrier.
February 4, 201934. Neuroinvasion, Encephalitis and Neuron Death with SARS-CoV-2.
January 19, 202135. Jean claude Perez § Luc Montagnier - COVID-19, SARS and Bats Coronaviruses Genomes Unexpected Exogenous RNA Sequences
May 29, 202036. Jean claude Perez § Luc Montagnier - COVID-19, COVID-19, SARS and Bats Coronaviruses Genomes Peculiar Homologous RNA Sequences
July 7, 202037. Autopsy Findings of InflammoThrombotic Response (ITR) in Patients with COVID-19
JAugust 18, 202038. TMPRSS2 and Furin Both Essential for SARS-CoV-2 Infection of Cells.
July 23, 202039. Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1
March 22, 202040. Treatment of SARS-CoV-2 & COVID-19.
February 8, 2021
41. Evidence of Gain-of-Function.
September 14, 202042. Gain-of-Function Hall of Shame.
October 1, 202043. Origins of SARS-CoV-2.
February 7, 202144. Genetic Structure of SARS-CoV-2.
October 16, 2020
45. Origins of SARS and PRRA.
August 12, 202046. The Corona Conspiracy.
October 202047. Probabilities of SARS-CoV-2 Origin.
November 12, 202048. The Fauci COVID-19 Dossier.
February 18, 202149. Primate studies show Inflammation in Brain & Lewy Bodies.
February 23, 202150. Patent for PRRA Furin Cleavage Site with Certain Patent Rights Owned by U.S. Governmnent (NIH).
May 29, 200751. Janssen (Johnson & Johnson) EUA Document.
February 26, 202152. Ad26 [J & J]Prior Studies Reveal Only Temporary Immunity.
July 18, 201253. The Coxsackie & Adenovirus Receptor (CAR).
June 8, 199954. Deleted Wuhan Databases.
February 23, 202155. CDC Document on Adenovirus Vaccines.
January 8, 202056. COVID-19 Vaccines and Brain Injury.
April 10, 202157. SARS-CoV-2 Accelerates Amyloid Formation.
April 12, 202158. SARS-CoV-2 Is an Unrestricted Bioweapon.
Released April 24, 202159. SARS-CoV-2 is a Sophisticated Lab Modification.
Released April 24, 202160. CNN Lies and Misinformation.
September 14, 202061. SARS-CoV-2 - A Scientific Discussion of Lab Origin.
March 25, 202162. Lethal Deception.
April 22, 202163. Reverse Transcription of SARS-CoV-2 in Human Cells.
March 29, 202164. Evidence in Support of SARS-CoV-2 (Viral)-Human Cell Chimers.
March 29, 2021COVID Research | Fleming-Method
www.flemingmethod.com
Last edited: